HEALTH

Medicare to Cover Weight Loss Drugs: A $35 Billion Deal

USAFri Nov 07 2025

Key Details

  • Effective Date: January 2026
  • Drugs Covered: Ozempic, Wegovy, and other weight loss medications
  • Price Reductions:
  • Ozempic: $350/month (down from $1,000)
  • Wegovy: $350/month (down from $1,350)
  • Other Drugs: Around $145/month

Background

Until recently, Medicare could not cover drugs solely for weight loss. The rules have been evolving as these drugs also show benefits for heart disease. However, covering weight loss alone has been slow due to outdated regulations and cost concerns.

Financial Impact

  • Government Cost: The deal is expected to add $35 billion to federal spending from 2026 to 2034.
  • Cost per Person: Around $5,600 in 2026.
  • National Debt: Already over $38 trillion, this deal could further increase the debt.

questions

    How will the new Medicare coverage for GLP-1 drugs impact the overall healthcare budget in the long term?
    What are the potential health outcomes for patients who switch from higher-priced to lower-priced GLP-1 drugs?
    How will the new pricing structure for GLP-1 drugs affect the pharmaceutical industry's revenue and innovation?

actions